Ectopic expression of CCL19 impairs alloimmune response in mice
Open Access
- 20 April 2004
- journal article
- Published by Wiley in Immunology
- Vol. 112 (2) , 301-309
- https://doi.org/10.1111/j.1365-2567.2004.01859.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in theplt/pltmouseProceedings of the National Academy of Sciences, 2000
- The CC Chemokine CKβ-11/MIP-3β/ELC/Exodus 3 Mediates Tumor Rejection of Murine Breast Cancer Cells Through NK CellsThe Journal of Immunology, 2000
- CCR7 Ligands, SLC/6Ckine/Exodus2/TCA4 and CKβ-11/MIP-3β/ELC, Are Chemoattractants for CD56+CD16−NK Cells and Late Stage Lymphoid ProgenitorsCellular Immunology, 1999
- Lack of correlation between rejection of tumor cells co‐expressing interleukin‐2 and B7.1 and vaccine efficiencyEuropean Journal of Immunology, 1997
- Molecular Cloning of a Novel Human CC Chemokine EBI1-ligand Chemokine That Is a Specific Functional Ligand for EBI1, CCR7Journal of Biological Chemistry, 1997
- Suppression of cell-mediated and humoral immune responses by an interleukin-2-immunoglobulin fusion protein in mice.Journal of Clinical Investigation, 1996
- Cloning of Human and Mouse EBI1, a Lymphoid-Specific G-Protein-Coupled Receptor Encoded on Human Chromosome 17q12-q21.2Genomics, 1994
- Determination of lymphocyte division by flow cytometryJournal of Immunological Methods, 1994
- Expression of tumor necrosis factor by different tumor cell lines results either in tumor suppression or augmented metastasis.The Journal of Experimental Medicine, 1993
- Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma.Proceedings of the National Academy of Sciences, 1993